•
Mar 31, 2021
Elanco Q1 2021 Earnings Report
Elanco reported better than expected results, building on the strong momentum since closing the Bayer Animal Health acquisition in August 2020.
Key Takeaways
Elanco's first quarter 2021 results exceeded expectations, driven by broad-based outperformance across categories and geographies. The company is updating its full year 2021 guidance, raising and tightening adjusted ranges.
Revenue was $1,242 million, an increase of 89 percent compared to the first quarter of 2020.
Global Pet Health business drove approximately half of the upside versus the midpoint of first quarter guidance.
Innovation pipeline is on track to yield eight launches in 2021.
Company completed the transition to its standalone ERP system during the first quarter.
Elanco
Elanco
Forward Guidance
Elanco is raising and tightening its full year 2021 guidance for revenue, adjusted EBITDA, and adjusted earnings per share.